Head-to-Head

Abbott Laboratories vs. Dermata Therapeutics, Inc. Common Stock

ABT

Abbott Laboratories

$104.71 -2.55%

VS DRMA

Dermata Therapeutics, Inc. Common Stock

$0.57 -4.75%

Abbott Laboratories and Dermata Therapeutics, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.

Size & Scale

ABTDRMA
Market Cap $186.10 billion $2.95 million

ABT leads on 1 of 1 size & scale factors.

Dividend

ABTDRMA
Dividend Yield 2.41% —

ABT and DRMA split the dividend factors evenly.

Risk & Sentiment

ABTDRMA
Short Interest 0.57% 0.32%

DRMA leads on 1 of 1 risk & sentiment factors.

Dig deeper: ABT overview, ABT financials, DRMA overview, DRMA financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.